September 01, 2026
Law360 Healthcare Authority looks at a Fifth Circuit ruling backing the removal of certain GLP-1 medications from the national drug shortage list, the dismissal of AstraZeneca's challenge to a Colorado law affecting drug distribution under the federal 340B drug discount program and other litigation outcomes impacting the healthcare industry.
August 28, 2026
Walmart has agreed to pay $50 million to settle the U.S. Department of Justice's nearly 6-year-old lawsuit in Delaware federal court alleging the big-box retailer helped spur the nationwide opioid crisis by unlawfully dispensing controlled drugs from its pharmacies, the department announced Friday.
March 11, 2024
A Delaware federal judge on Monday kept alive a government lawsuit accusing Walmart of fueling the nation's opioid crisis, ruling that the company could be held liable for filling illegitimate prescriptions its compliance officers allegedly failed to flag for unwitting pharmacists.
June 27, 2023
Against long odds, two doctors facing decades in prison implored the U.S. Supreme Court to harmonize jury instructions in opioid crisis prosecutions, insisting that innocence in one circuit could be guilt in another. They ultimately prevailed, but one year later, the circuit split surprisingly appears even starker, as one of the doctors eyes freedom, and the other still might live out his life behind bars.
February 17, 2023
Walmart is urging a Delaware federal judge to dump much of the U.S. Department of Justice lawsuit targeting the big-box retailer's sales of prescription opioids, arguing that the government can't pin liability on Walmart for pharmacists who unknowingly filled allegedly invalid prescriptions.
January 18, 2023
The government urged a Delaware federal judge Tuesday to deny Walmart's attempt to escape much of the U.S. Department of Justice lawsuit targeting the big-box retailer's sales of prescription opioids, arguing that Walmart's narrow interpretation of the law would "weaken" the Controlled Substances Act and allow companies to skirt reporting obligations.
December 16, 2022
Michael Carvin, the brusque, cigar-chomping attorney best known for forcefully championing conservative causes in the Supreme Court, is retiring after more than 20 years at Jones Day.
November 07, 2022
Walmart is asking a Delaware federal judge to throw out most of a U.S. Department of Justice lawsuit targeting the big-box retailer's sales of prescription opioids, saying the latest version of the case is far too broad.
October 11, 2022
Amid the U.S. Supreme Court's new standards for Controlled Substances Act cases, the U.S. Department of Justice is striving to salvage a sweeping suit targeting Walmart's sales of prescription narcotics, insisting that company officials "routinely ignored" their own suspicions about opioid orders.
November 22, 2021
The U.S. Department of Justice's sweeping lawsuit contending that Walmart's 5,000 pharmacies "helped fuel a national crisis" of opioid abuse is being halted until the U.S. Supreme Court decides newly accepted cases involving the boundaries of Controlled Substances Act enforcement, a Delaware federal judge ruled.